TEK2day FINANCE Open Terminal →

Sunshine Biopharma Inc. (SBFM)

US Markets · Healthcare · Drug Manufacturers - Specialty & Generic

$2.22 -6.33%

Closing price as of 2026-06-12 · Source: TEK2day Finance

1-Year Price History -78.4% over period
$11$9$6$4$2 2026-052026-052026-052026-062026-06

Key Metrics

Market Cap
$6.8M

About Sunshine Biopharma Inc.

Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, dermatology, smoking cessation, cholelithiasis, anticonvulsant, urology, women's health, acid reflux, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.

Want live quotes, estimates, SEC filings, and CEO analytics for SBFM?
The free TEK2day terminal runs in your browser — type /SBFM to get started.
Open SBFM in the Terminal →